U.S. market Closed. Opens in 1 day 10 hours 16 minutes

ALC | Alcon Inc. Stock Overview

(Stock Exchange: NYSE)
Day's Range 84.14 - 85.33
52 Week Range 74.30 - 101.10
Beta 1.22
Implied Volatility 20.85%
IV Rank 16.87%
Day's Volume 860,724
Average Volume 799,865
Shares Outstanding 493,300,000
Market Cap 41,812,108,000
Sector Healthcare
Industry Medical - Instruments & Supplies
IPO Date 2019-04-09
Valuation
Profitability
Growth
Health
P/E Ratio 36.22
Forward P/E Ratio N/A
EPS 2.34
1YR Price Target N/A
Dividend Yield 0.31%
Dividend Per Share 0.27
Dividend ExDate N/A
Dividend PayDate N/A
Employees 25,000
Country Switzerland
Website ALC
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
ALC's peers: TFX, WST, RMD, ICUI, COO, ANGO, ATR, BLFS, HAE, MMSI, NVST, EMBC, BAX, BDX, HOLX, STVN, WRBY, XRAY, BLCO
*Chart delayed
Analyzing fundamentals for ALC we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is good and Health is frighteningly weak. For more detailed analysis please see ALC Fundamentals page.

Watching at ALC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ALC Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙